Edgewise Therapeutics Inc. Common Stock vs Valaris Limited Common Shares — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.13 (market cap $3.94B), while Valaris Limited Common Shares trades at $84.6 (market cap $5.94B). The key difference: Valaris Limited Common Shares is the larger of the two by market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, Valaris Limited Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Valaris Limited Common Shares for 0 Days on average.
| EWTX | VAL | |
|---|---|---|
Market Cap | $3.94B | $5.94B |
Volume | 810,104 | 742,554 |
Sector | Health | Energy |
52-Week High | $48.35 | $113.42 |
52-Week Low | $14.89 | $48.15 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.48B | $6.56B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →Valaris Limited provides offshore contract drilling services to the oil and gas industry, operating a fleet of drillships, semisubmersibles, and jackup rigs across multiple regions worldwide.
Read more on VAL →